Abstract
Over the past decade, the original concept of macrophage activation as development of the ability to destroy facultative or obligate intracellular parasites has been broadened to include the destruction of tumor cells (1). Macrophages from sites of infection with such intracellular parasites, when cocultivated with tumor cells, efficiently destroy the tumor cells over several days (1). This form of cytolysis, which has been termed macrophage-mediated tumor cytotoxicity, has generally been found to be selective for tumor cells, to depend upon cell-to-cell contact, and to be independent of either exogenous recognition factors or soluble lytic substances (2,3). In the past two years, it has become apparent that macrophages can also be activated for destroying tumor cells in another, quite distinct circumstance — the lysis of antibody-coated tumor targets (antibody-dependent cellular cytotoxicity or ADCC) (4,5). Considerable evidence has been amassed that activation of macrophages is an important host defense against the development and spread of neoplasms in vivo (1–3).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Hibbs, J. B., Remington, J. S., and Stewart, C. C., Pharmacol. Ther. 8:37, 1980.
Evans, R., and Alexander, P., in “Immunobiology of the Macrophage”, p. 536, (D. S. Nelson, ed.), Academic Press, New York, 1976.
Keller, R., in “The Macrophage and Cancer” (K. James, B. McBride and A. Stewart, eds.), pp. 31-49, 1977.
Koren, H. S., and Adams, D. O., in “Macrophage Mediated Antibody-Dependent Cellular Cytotoxicity” (H. S. Koren, ed.), Plenum Press, New York, in press.
Nathan, C. F., Fed. Proc., in press, April, 1982.
Adams, D. O., and Marino, P., in “Contemporary Hematology-Oncology”, vol. III, (A. S. Gordon, R. Silber and J. LoBue, eds.), Plenum Publishing Corp., New York, in preparation, 1982.
Meltzer, M. S., Tucker, R. W., and Breuer, A. C., Cell. Immunol. 17:30, 1975.
Stewart, C., Adles, C., and Hibbs, J.B., in “The RES in Health and Disease”, (H. Friedman, M. Escobar, and S. Reichard, eds.). Plenum Press, New York, 1975.
Piessens, W., Cell. Immunol. 35:303, 1978.
Marino, P. A., and Adams, D. O., Cell. Immunol. 54:11, 1980.
Somers, S. D., and Adams, D. O., manuscript in preparation, 1982.
Johnson, W. J., Whisnant, C. C., and Adams, D. O., J. Immunol. 127:1787, 1981.
Hollenberg, M. D., and Cuatrecasas, P., in “The Receptors”, Vol. 1, General Principles and Procedures, Plenum Publishing Corp., New York, 1979.
Adams, D. O., Johnson, W. J., and Marino, P. A., Fed. Proc., in press, April, 1982.
Somers, S. D., and Adams, D. O., in “Natural Cell-Mediated Immunity. II” (R. Herberman, ed.), Academic Press, New York, in press, 1982.
Marino, P. A., Whisnant, C. C., and Adams, D. O., J. Exp. Med. 154:77, 1981.
Adams, D. O., Marino, P. A., and Meltzer, M. S., J. Immunol. 126:1843, 1981.
Adams, D. O., and Marino, P. A., J. Immunol. 126:981, 1981.
Adams, D. O., Kao, K. J., Farb, R., and Pizzo, S. V., J. Immunol. 124:293, 1980.
Adams, D. O., J. Immunol. 124:286, 1980.
Johnson, W. J., Weiel, J. E., and Adams, D. O., in “Natural Cell-Mediated Immunity. II.” (R. Herberman, ed.), Academic Press, New York, in press, 1982.
Adams, D. O., Johnson, W. J., Fiorito, E., and Nathan, C. F., J. Immunol. 127:1973, 1981.
Johnson, W. J., and Adams, D. O., unpublished observations, 1982.
Hibbs, J. B., Taintor, R. R., Chapman, H. A., and Weinberg, J. B., Science 197:279, 1977.
Meltzer, M. S., Lymphokines 3:319, 1981.
Russell, S. W., Doe, W. F., and Mclntosh, A. T., J. Exp. Med. 146:1151, 1977.
Buchmüller, Y., and Mauel, J., J. Exp. Med. 150:359, 1979.
Cohn, Z. A., J. Immunol. 121:813, 1978.
Adams, D. O., and Dean, J. H., in “Natural Cell-Mediated Immunity. II.” (R. Herberman, ed.), Academic Press, New York, in press, 1982.
Adams, D. O., Johnson, W. J., and Marino, P. A., manuscript in preparation, 1982.
Nathan, C. F., and Root, R. K., J. Exp. Med. 146:1648, 1977.
Edelson, P., Lymphokines 3:57, 1981.
Ezekowitz, R. A. B., Austyn, J., Stahl, P. D., and Gomer, S., J. Exp. Med. 154:60, 1981.
Beller, D. I., Kiely, J., and Unkeless, E., J. Immunol. 124:1426, 1980.
Imber, M. J., Pizzo, S. V., Johnson, W. J., and Adams, D. O., J. Cell Biol., in press, 1982.
Marino, P., and Adams, D. O., J. Immunol., in press, 1982.
Johnson, W. J. Pizzo, S. V., Imber, M. J., and Adams, D. O., submitted for publication, 1982.
Adams, D. O., Johnson, W. J., Marino, P., and Dean, J., submitted for publication, 1982.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Adams, D.O., Johnson, W.J. (1982). Activation of Murine Mononuclear Phagocytes for Destroying Tumor Cells: Analysis of Effector Mechanisms and Development. In: Normann, S.J., Sorkin, E. (eds) Macrophages and Natural Killer Cells. Advances in Experimental Medicine and Biology, vol 155. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4394-3_78
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4394-3_78
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4396-7
Online ISBN: 978-1-4684-4394-3
eBook Packages: Springer Book Archive